BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6427276)

  • 1. An unusual pattern of peptide-bound lysine metabolism in collagen from an infant with lethal perinatal osteogenesis imperfecta.
    Petrovic OM; Miller EJ
    J Clin Invest; 1984 Jun; 73(6):1569-75. PubMed ID: 6427276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteogenesis imperfecta congenita: evidence for a generalized molecular disorder of collagen.
    Trelstad RL; Rubin D; Gross J
    Lab Invest; 1977 May; 36(5):501-8. PubMed ID: 865078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collagen defects in lethal perinatal osteogenesis imperfecta.
    Bateman JF; Chan D; Mascara T; Rogers JG; Cole WG
    Biochem J; 1986 Dec; 240(3):699-708. PubMed ID: 3827862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disorder of collagen metabolism in a patient with osteogenesis imperfecta (lethal type): increased degree of hydroxylation of lysine in collagen types I and III.
    Kirsch E; Krieg T; Remberger K; Fendel H; Bruckner P; Müller PK
    Eur J Clin Invest; 1981 Feb; 11(1):39-47. PubMed ID: 6783428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal type I collagen metabolism by cultured fibroblasts in lethal perinatal osteogenesis imperfecta.
    Bateman JF; Mascara T; Chan D; Cole WG
    Biochem J; 1984 Jan; 217(1):103-15. PubMed ID: 6421277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyridinium cross-links in bone of patients with osteogenesis imperfecta: evidence of a normal intrafibrillar collagen packing.
    Bank RA; Tekoppele JM; Janus GJ; Wassen MH; Pruijs HE; Van der Sluijs HA; Sakkers RJ
    J Bone Miner Res; 2000 Jul; 15(7):1330-6. PubMed ID: 10893681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compositional analysis of collagen from patients with diverse forms of osteogenesis imperfecta.
    Kirsch E; Krieg T; Nerlich A; Remberger K; Meinecke P; Kunze D; Müller PK
    Calcif Tissue Int; 1987 Jul; 41(1):11-7. PubMed ID: 3113698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered ratio of collagen chains in bone of a patient with non-lethal osteogenesis imperfecta.
    Sokolov BP; Sher BM; Hausmann J; Marik I; Deyl Z; Kalinin VN
    Biochim Biophys Acta; 1992 Feb; 1138(2):93-6. PubMed ID: 1540665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Osteogenesis imperfecta: contribution to pathobiochemistry].
    Pontz BF; Müller PK
    Padiatr Padol; 1984; 19(4):365-70. PubMed ID: 6504544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of cyanogen bromide peptides of type I collagen from a patient with lethal osteogenesis imperfecta.
    Kirsch E; Glanville RW; Krieg T; Müller P
    Biochem J; 1983 Jun; 211(3):599-603. PubMed ID: 6411063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of osteogenesis imperfecta. Biochemical and morphological findings in a case of type III according to Sillence.
    Stöss H; Pontz BF; Pesch HJ; Ott R
    Eur J Pediatr; 1986 Apr; 145(1-2):34-9. PubMed ID: 3732329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A structural mutation of the collagen alpha 1(I)CB7 peptide in lethal perinatal osteogenesis imperfecta.
    Bateman JF; Mascara T; Chan D; Cole WG
    J Biol Chem; 1987 Apr; 262(10):4445-51. PubMed ID: 3558348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relative amounts of the collagen chains alpha 1(I), alpha 2 and alpha 1(III) in the skin of 31 patients with osteogenesis imperfecta.
    Francis MJ; Williams KJ; Sykes BC; Smith R
    Clin Sci (Lond); 1981 Jun; 60(6):617-23. PubMed ID: 6788428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxylation of collagen type I: evidence that both lysyl and prolyl residues are overhydroxylated in osteogenesis imperfecta.
    Lehmann HW; Rimek D; Bodo M; Brenner RE; Vetter U; Wörsdörfer O; Karbowski A; Müller PK
    Eur J Clin Invest; 1995 May; 25(5):306-10. PubMed ID: 7628516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lethal osteogenesis imperfecta with amniotic band lesions: collagen studies.
    van der Rest M; Hayes A; Marie P; Desbarats M; Kaplan P; Glorieux FH
    Am J Med Genet; 1986 Jul; 24(3):433-46. PubMed ID: 3728562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dentine is biochemically abnormal in osteogenesis imperfecta.
    Gage JP; Francis MJ; Whitaker GE; Smith R
    Clin Sci (Lond); 1986 Apr; 70(4):339-46. PubMed ID: 3084156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteogenesis imperfecta: biochemical studies of bone collagen.
    Fujii K; Tanzer ML
    Clin Orthop Relat Res; 1977 May; (124):271-7. PubMed ID: 598086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysyl hydroxylation in collagens from hyperplastic callus and embryonic bones.
    Lehmann HW; Bodo M; Frohn C; Nerlich A; Rimek D; Notbohm H; Müller PK
    Biochem J; 1992 Mar; 282 ( Pt 2)(Pt 2):313-8. PubMed ID: 1546948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The amino-acid composition of human hard tissue collagens in osteogenesis imperfecta and dentinogenesis imperfecta.
    Eastoe JE; Martens P; Thomas NR
    Calcif Tissue Res; 1973 May; 12(2):91-100. PubMed ID: 4710795
    [No Abstract]   [Full Text] [Related]  

  • 20. Composition, cross-linking and thermal stability of bone and skin collagens in patients with osteogenesis imperfecta.
    Herbage D; Borsali F; Buffevant C; Flandin F; Aguercif M
    Metab Bone Dis Relat Res; 1982; 4(2):95-101. PubMed ID: 6815415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.